This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB03671/identifier/chemspider/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB03671/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03671/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03671/identifier/pubchem-substance/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03671/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03671
rdf:type
n3:Drug
n3:description
3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. [PubChem]
n3:group
experimental
owl:sameAs
n13:DB03671 n14:DB03671
dcterms:title
4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One
adms:identifier
n6:46509019 n7:DOG n8:46936752 n10:529067 n11:DB03671
n3:IUPAC-Name
n4:271B5E90-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5E96-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5E95-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5E92-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5E93-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5E94-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5E8E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5E8C-363D-11E5-9242-09173F13E4C5 n4:271B5E8F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5E8D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5E9C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5E9D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5E97-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5E98-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5E9A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5E99-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5E9B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5EA2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5EA4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5EA5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5EA1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5EA0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5EA3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5E91-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5E9E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5E9F-363D-11E5-9242-09173F13E4C5